Revisiting a risk benefit analysis of mRNA COVID-19 vaccines during the omicron era

Am J Epidemiol. 2023 Dec 13:kwad242. doi: 10.1093/aje/kwad242. Online ahead of print.NO ABSTRACTPMID:38100362 | DOI:10.1093/aje/kwad242

Source: Am J Epidemiol - December 15, 2023 Category: Epidemiology Authors: Raphael Lataster Source Type: research